331 related articles for article (PubMed ID: 14506510)
1. Analysis of the hypericin and pseudohypericin content of commercially available St John's Wort preparations.
Draves AH; Walker SE
Can J Clin Pharmacol; 2003; 10(3):114-8. PubMed ID: 14506510
[TBL] [Abstract][Full Text] [Related]
2. Determination of total hypericins in St. John's wort and herbal medicinal products.
Anyzewska M; Kowalczuk A; Łozak A; Jabłczyńska R; Fijałek Z
Acta Pol Pharm; 2010; 67(6):586-92. PubMed ID: 21229872
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of methods for determination of naphthodianthrones and flavonoids in St. John's wort.
Williams FB; Sander LC; Wise SA; Girard J
J Chromatogr A; 2006 May; 1115(1-2):93-102. PubMed ID: 16554056
[TBL] [Abstract][Full Text] [Related]
4. Determination of hypericin and pseudohypericin in pharmaceutical preparations by liquid chromatography with fluorescence detection.
Draves AH; Walker SE
J Chromatogr B Biomed Sci Appl; 2000 Nov; 749(1):57-66. PubMed ID: 11129079
[TBL] [Abstract][Full Text] [Related]
5. Content analysis and stability evaluation of selected commercial preparations of St. John's wort.
Shah AK; Avery BA; Wyandt CM
Drug Dev Ind Pharm; 2005 Oct; 31(9):907-16. PubMed ID: 16306003
[TBL] [Abstract][Full Text] [Related]
6. Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans.
Brockmöller J; Reum T; Bauer S; Kerb R; Hübner WD; Roots I
Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():94-101. PubMed ID: 9342768
[TBL] [Abstract][Full Text] [Related]
7. A high-performance liquid chromatography with electrochemical detection for the determination of total hypericin in extracts of St. John's Wort.
Rückert U; Eggenreich K; Likussar W; Wintersteiger R; Michelitsch A
Phytochem Anal; 2006; 17(3):162-7. PubMed ID: 16749423
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of total hypericin and hyperforin in St. John's wort extracts by HPLC with electrochemical detection.
Rückert U; Likussar W; Michelitsch A
Phytochem Anal; 2007; 18(3):204-8. PubMed ID: 17500362
[TBL] [Abstract][Full Text] [Related]
9. TESTING PHARMACEUTICAL RELEASE OF ACTIVE SUBSTANCES FROM MEDICINAL PRODUCTS CONTAINING ST. JOHN'S WORT.
Sakowska J; Anyzewska M; Łozak A; Kowalczuk A; Jabłczyńska R
Acta Pol Pharm; 2016; 73(2):395-401. PubMed ID: 27180432
[TBL] [Abstract][Full Text] [Related]
10. Clinic at the health food store? Employee recommendations and product analysis.
Glisson JK; Rogers HE; Abourashed EA; Ogletree R; Hufford CD; Khan I
Pharmacotherapy; 2003 Jan; 23(1):64-72. PubMed ID: 12523461
[TBL] [Abstract][Full Text] [Related]
11. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
Markowitz JS; DeVane CL
Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of the predominant hyperforins and hypericins in St. John's Wort (Hypericum perforatum L.) by liquid chromatography.
Gray DE; Rottinghaus GE; Garrett HE; Pallardy SG; Gray DE; Rottinghaus GE; Garrett HE; Pallardy SG
J AOAC Int; 2000; 83(4):944-9. PubMed ID: 10995119
[TBL] [Abstract][Full Text] [Related]
13. Comparison of German St. John's wort products according to hyperforin and total hypericin content.
Wurglics M; Westerhoff K; Kaunzinger A; Wilke A; Baumeister A; Dressman J; Schubert-Zsilavecz M
J Am Pharm Assoc (Wash); 2001; 41(4):560-6. PubMed ID: 11486982
[TBL] [Abstract][Full Text] [Related]
14. St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1.
Schwarz D; Kisselev P; Roots I
Cancer Res; 2003 Nov; 63(22):8062-8. PubMed ID: 14633740
[TBL] [Abstract][Full Text] [Related]
15. [Flavonoid and dianthranoid levels of the St.-John's-wort flowering tops].
Girzu-Amblard M; Carnat A; Fraisse D; Carnat AP; Lamaison JL
Ann Pharm Fr; 2000 Oct; 58(5):341-5. PubMed ID: 11060411
[TBL] [Abstract][Full Text] [Related]
16. About the cover: St. John's wort.
J Soc Integr Oncol; 2006; 4(1):52-5. PubMed ID: 16737673
[TBL] [Abstract][Full Text] [Related]
17. Development of a simple, rapid and reproducible HPLC assay for the simultaneous determination of hypericins and stabilized hyperforin in commercial St. John's wort preparations.
de los Reyes GC; Koda RT
J Pharm Biomed Anal; 2001 Dec; 26(5-6):959-65. PubMed ID: 11600308
[TBL] [Abstract][Full Text] [Related]
18. Determination of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts by liquid chromatography/tandem mass spectrometry.
Tolonen A; Uusitalo J; Hohtola A; Jalonen J
Rapid Commun Mass Spectrom; 2002; 16(5):396-402. PubMed ID: 11857723
[TBL] [Abstract][Full Text] [Related]
19. Mood-enhancing antidepressant St. John's wort inhibits the activation of human immunodeficiency virus gene expression by ultraviolet light.
Taher MM; Lammering GM; Hershey CM; Valerie KC
IUBMB Life; 2002 Dec; 54(6):357-64. PubMed ID: 12665247
[TBL] [Abstract][Full Text] [Related]
20. Effects of St. John's wort supplementation on ibuprofen pharmacokinetics.
Bell EC; Ravis WR; Lloyd KB; Stokes TJ
Ann Pharmacother; 2007 Feb; 41(2):229-34. PubMed ID: 17284505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]